Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Naturwissenschaften ; 107(2): 13, 2020 Mar 03.
Artículo en Inglés | MEDLINE | ID: mdl-32125545

RESUMEN

Early endosymbiotic interactions are recorded only from a Cretaceous termite and a cockroach. Mesoblatta maxi Hinkelman, gen. et sp. nov. is the second representative of the dominant, cosmopolitan Mesozoic family Mesoblattinidae known from Cenomanian northern Myanmar amber, and the fourteenth from both amber and sedimentary rocks. Unique characters are rare (n = 19), symplesiomorphies are frequent (n = 140), and foremost is a standard maxillary palp, an irregular area between forewing veins radius and media, central ocellus, and multisegmented styli, suggesting an ancestral position with respect to Blattidae. Autapomorphies of this otherwise conservative taxon are only its large size and a short probasitarsus. Two nymphs with fecal pellets protruding from their body, Blattocoprolites mesoblattamaxi Hinkelman, ichogen. et ichnosp. nov., represent the first cockroaches with formalized coprolites (along with Blattocoprolites blattulidae Hinkelman, ichnosp. nov. established herein from Lebanese amber) and provide evidence of burial defecation. Subhomogenic consistency of coprolites with mucous components, "pseudoinclusions," leaf, trichia, wood debris, cycad pollen, endosymbiotic protists, and epibiotic bacteria directly document pollen transfer through the digestive tract and the earliest coevolution with protists and bacteria. Other post-burial fecal bacteria at the surface are documented for the first time in the Mesozoic, directly indicating structured dung processing. Reference samples (as well as almost all Myanmar amber samples) contain numerous "pseudoinclusions," probably representing damaged or dead cysts of Chlamydomonas hanublikanus Vrsanská et Hinkelman, sp. nov. established on the basis of its reproductive stages (with an origin within the resin inside the tree). These are documented together with green algae, including Spirogyra Nees, 1820; flagellates; and flagellate amoebae, promoting massive future microbiota studies.


Asunto(s)
Ámbar , Cucarachas/microbiología , Cucarachas/parasitología , Heces , Fósiles , Polen , Animales , Heces/citología , Heces/microbiología , Mianmar
2.
J Gastroenterol ; 52(4): 452-465, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-27329502

RESUMEN

BACKGROUND: A defined Microbial Ecosystem Therapeutic (MET-1, or "RePOOPulate") derived from the feces of a healthy volunteer can cure recurrent C. difficile infection (rCDI) in humans. The mechanisms of action whereby healthy microbiota protect against rCDI remain unclear. Since C. difficile toxins are largely responsible for the disease pathology of CDI, we hypothesized that MET-1 exerts its protective effects by inhibiting the effects of these toxins on the host. METHODS: A combination of in vivo (antibiotic-associated mouse model of C. difficile colitis, mouse ileal loop model) and in vitro models (FITC-phalloidin staining, F actin Western blots and apoptosis assay in Caco2 cells, transepithelial electrical resistance measurements in T84 cells) were employed. RESULTS: MET-1 decreased both local and systemic inflammation in infection and decreased both the cytotoxicity and the amount of TcdA detected in stool, without an effect on C. difficile viability. MET-1 protected against TcdA-mediated damage in a murine ileal loop model. MET-1 protected the integrity of the cytoskeleton in cells treated with purified TcdA, as indicated by FITC-phalloidin staining, F:G actin assays and preservation of transepithelial electrical resistance. Finally, co-incubation of MET-1 with purified TcdA resulted in decreased detectable TcdA by Western blot analysis. CONCLUSIONS: MET-1 intestinal microbiota confers protection against C. difficile and decreases C. difficile-mediated inflammation through its protective effects against C. difficile toxins, including enhancement of host barrier function and degradation of TcdA. The effect of MET-1 on C. difficile viability seems to offer little, if any, contribution to its protective effects on the host.


Asunto(s)
Toxinas Bacterianas/antagonistas & inhibidores , Terapia Biológica/métodos , Clostridioides difficile/crecimiento & desarrollo , Enterocolitis Seudomembranosa/prevención & control , Enterotoxinas/antagonistas & inhibidores , Microbioma Gastrointestinal , Animales , Toxinas Bacterianas/metabolismo , Células CACO-2 , Clostridioides difficile/aislamiento & purificación , Citoesqueleto/patología , Modelos Animales de Enfermedad , Enterocolitis Seudomembranosa/microbiología , Enterocolitis Seudomembranosa/patología , Enterotoxinas/metabolismo , Heces/química , Heces/citología , Heces/microbiología , Fibroblastos/patología , Humanos , Ratones Endogámicos C57BL
3.
Trop Anim Health Prod ; 45(1): 123-7, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22684690

RESUMEN

The aim of this study was to verify the in vivo effectiveness of pumpkin seed (Curcubita pepo Linnaeus, 1753) in naturally infected ostriches in the Cariri zone, semiarid region of Paraíba State, Brazil. Forty-eight ostriches were used, African Black breed, of 14 to 36 months old, naturally infected by gastrointestinal nematodes. These animals were divided into four groups of 12 ostriches. Group 1 consists of animals treated with 0.5 g/kg live weight (l. w.) of pumpkin seed meal; group 2 received 1 g/kg l. w. of pumpkin seed meal; group 3 was treated with Albendazole 5 %, at the dosage of 1 mL/10 kg l. w.; and Group 4 was the control group and do not received treatment. Groups 1 and 2 received the treatment for three consecutive days, orally, at intervals of 7 days, totaling nine administrations. The Albendazole 5 % was administered one time, at the beginning of the experiment, according to the manufacturer's recommendations. The groups treated with pumpkin seed showed a significant decrease in egg counts per gram of feces (EPG), wherein group 2 (1 g/kg l. w.) was the most effective. The control and drug groups showed no reduction in EPG. The results of the present study demonstrate that the administration of pumpkin seed was effective in controlling gastrointestinal helminths in naturally infected ostriches.


Asunto(s)
Enfermedades de las Aves/tratamiento farmacológico , Enfermedades de las Aves/parasitología , Cucurbita , Fitoterapia/métodos , Infecciones por Rhabditida/veterinaria , Semillas/química , Struthioniformes , Albendazol/farmacología , Crianza de Animales Domésticos/métodos , Animales , Brasil , Heces/citología , Tracto Gastrointestinal/parasitología , Recuento de Huevos de Parásitos/veterinaria , Infecciones por Rhabditida/tratamiento farmacológico
4.
J Proteome Res ; 11(12): 5924-33, 2012 Dec 07.
Artículo en Inglés | MEDLINE | ID: mdl-23075436

RESUMEN

Four healthy adult cats were used in a crossover design to determine phylogeny and metabolic functional capacity of the cat's gastrointestinal microbiota using a metagenomic approach. Healthy adult cats (1.7 years old) were fed diets containing 4% cellulose, fructooligosaccharides (FOS), or pectin for 30 d, at which time fresh fecal samples were collected. Fecal DNA samples from each cat consuming each diet were subjected to 454 pyrosequencing. Dominant phyla determined using two independent databases (MG-RAST and IMG/M) included Firmicutes (mean=36.3 and 49.8%, respectively), Bacteroidetes (mean=36.1 and 24.1%, respectively), and Proteobacteria (mean=12.4 and 11.1%, respectively). Primary functional categories as determined by KEGG were associated with carbohydrates, clustering-based subsystems, protein metabolism, and amino acids and derivatives. Primary functional categories as determined by COG were associated with amino acid metabolism and transport, general function prediction only, and carbohydrate transport and metabolism. Analysis of carbohydrate-active enzymes revealed modifications in several glycoside hydrolases, glycosyl transferases, and carbohydrate-binding molecules with FOS and pectin consumption. While the cat is an obligate carnivore, its gut microbiome is similar regarding microbial phylogeny and gene content to omnivores.


Asunto(s)
Fibras de la Dieta/administración & dosificación , Tracto Gastrointestinal/microbiología , Metagenoma , Aminoácidos/metabolismo , Animales , Bacteroidetes/clasificación , Bacteroidetes/crecimiento & desarrollo , Bacteroidetes/metabolismo , Gatos , Celulosa/metabolismo , Análisis por Conglomerados , Biología Computacional/métodos , Bases de Datos Genéticas , Fibras de la Dieta/metabolismo , Heces/citología , Heces/microbiología , Tracto Gastrointestinal/metabolismo , Masculino , Metabolómica/métodos , Oligosacáridos/metabolismo , Pectinas/metabolismo , Filogenia , Proteobacteria/clasificación , Proteobacteria/crecimiento & desarrollo , Proteobacteria/metabolismo , Distribución Aleatoria , Factores de Tiempo
5.
Int Arch Allergy Immunol ; 155 Suppl 1: 40-5, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21646794

RESUMEN

BACKGROUND: Eosinophilic gastrointestinal disorders (EGIDs) are disorders characterized by primary eosinophil inflammation in the gastrointestinal tract. There are a small number of reports of eosinophil infiltration in gastrointestinal tracts presenting as EGIDs in infants. In this study, we present Japanese cases of EGIDs in infants. METHODS: Five patients diagnosed with or strongly suspected to have EGIDs in our hospital from 2008 to 2010 were reviewed. Radiographic contrast enema examinations and/or endoscopies were performed in 4 and 3 patients, respectively. RESULTS: There were patients with eosinophilic colitis (1 suspected and 2 biopsy-proven), a patient who was suspected of having allergic eosinophilic enterocolitis, and a patient with eosinophilic gastroenteritis associated with pediatric hypereosinophilic syndrome. CONCLUSIONS: The causes and clinical findings of patients with intestinal eosinophil inflammation vary. Therefore, deliberate examination and observation are important for patients with infantile EGID.


Asunto(s)
Enteritis , Eosinofilia , Gastritis , Colon/patología , Anomalías Congénitas/patología , Constricción Patológica/patología , Eccema/complicaciones , Enteritis/sangre , Enteritis/complicaciones , Enteritis/diagnóstico , Enteritis/etiología , Enteritis/patología , Enteritis/terapia , Eosinofilia/sangre , Eosinofilia/complicaciones , Eosinofilia/diagnóstico , Eosinofilia/etiología , Eosinofilia/patología , Eosinofilia/terapia , Eosinófilos/patología , Heces/citología , Femenino , Mucosa Gástrica/patología , Gastritis/sangre , Gastritis/complicaciones , Gastritis/diagnóstico , Gastritis/etiología , Gastritis/patología , Gastritis/terapia , Humanos , Síndrome Hipereosinofílico/sangre , Síndrome Hipereosinofílico/complicaciones , Síndrome Hipereosinofílico/patología , Inmunoglobulina E/sangre , Inmunoglobulina E/inmunología , Lactante , Recién Nacido , Mucosa Intestinal/patología , Japón , Masculino , Hipersensibilidad a la Leche/complicaciones , Hipersensibilidad a la Leche/inmunología , Miocarditis/complicaciones , Sangre Oculta , Prednisolona/uso terapéutico , Recto/patología , Síndrome
6.
J Nutr ; 141(6): 1029-35, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21508209

RESUMEN

We have demonstrated that fish oil- and pectin-containing (FO/P) diets protect against colon cancer compared with corn oil and cellulose (CO/C) by upregulating apoptosis and suppressing proliferation. To elucidate the mechanisms whereby FO/P diets induce apoptosis and suppress proliferation during the tumorigenic process, we analyzed the temporal gene expression profiles from exfoliated rat colonocytes. Rats consumed diets containing FO/P or CO/C and were injected with azoxymethane (AOM; 2 times, 15 mg/kg body weight, subcutaneously). Feces collected at initiation (24 h after AOM injection) and at aberrant crypt foci (ACF) (7 wk postinjection) and tumor (28 wk postinjection) stages of colon cancer were used for poly (A)+ RNA extraction. Gene expression signatures were determined using Codelink arrays. Changes in phenotypes (ACF, apoptosis, proliferation, and tumor incidence) were measured to establish the regulatory controls contributing to the chemoprotective effects of FO/P. At initiation, FO/P downregulated the expression of 3 genes involved with cell adhesion and enhanced apoptosis compared with CO/C. At the ACF stage, the expression of genes involved in cell cycle regulation was modulated by FO/P and the zone of proliferation was reduced in FO/P rats compared with CO/C rats. FO/P also increased apoptosis and the expression of genes that promote apoptosis at the tumor endpoint compared with CO/C. We conclude that the effects of chemotherapeutic diets on epithelial cell gene expression can be monitored noninvasively throughout the tumorigenic process and that a FO/P diet is chemoprotective in part due to its ability to affect expression of genes involved in apoptosis and cell cycle regulation throughout all stages of tumorigenesis.


Asunto(s)
Neoplasias del Colon/genética , Neoplasias del Colon/prevención & control , Enterocitos/metabolismo , Aceites de Pescado/administración & dosificación , Pectinas/administración & dosificación , Animales , Azoximetano/toxicidad , Ciclo Celular/genética , Proliferación Celular , Neoplasias del Colon/patología , Dieta , Grasas Insaturadas en la Dieta/administración & dosificación , Sacarosa en la Dieta/administración & dosificación , Enterocitos/citología , Enterocitos/efectos de los fármacos , Heces/química , Heces/citología , Perfilación de la Expresión Génica , Masculino , Análisis de Secuencia por Matrices de Oligonucleótidos , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley
7.
J Nutr ; 135(11): 2719-22, 2005 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16251637

RESUMEN

There is significant evidence supporting the hypotheses that lifestyle, diet, and bioactive components in foods are important modifiers of cancer risk. However, our ability to assess host response noninvasively is limited. To overcome this, we have developed a technology to isolate several million viable exfoliated somatic colonic cells from a small sample of stool (0.5-1.0 g) by a procedure known as somatic cell sampling and recovery (SCSR). Orally administered carotenoids appear in these cells several days after consuming the supplement, usually showing a peak concentration between 5-7 d after their ingestion. The time lag observed for the appearance of orally administered carotenoids in SCSR cells corresponds to the turnover rate of the colonic mucosa. This is an example of how changes in cell turnover rates can be carefully assessed using the SCSR system. The specific mechanisms by which individual constituents of diet affect the cancer process are not fully understood. However, host response to dietary constituents may be investigated, noninvasively, by following the modulation of tumor-associated molecular markers in these exfoliated SCSR cells. We have demonstrated the feasibility of using SCSR cells to detect the expression of carcinoembryonic antigen, CD44, and its splice variants, c-myc, c-erbb2, and mutations in the p53 gene. In this regard, SCSR cells are a readily available surrogate cellular target that may serve to monitor changes in cell turnover, differentiation, and expression of cancer-associated biomarkers that are likely to be modulated by bioactive food components.


Asunto(s)
Colon/citología , Dieta , Células Epiteliales/citología , Neoplasias/prevención & control , Biomarcadores de Tumor/análisis , Antígeno Carcinoembrionario/análisis , Carotenoides/administración & dosificación , Carotenoides/análisis , Carotenoides/farmacocinética , Diferenciación Celular , División Celular , Separación Celular/métodos , Células Epiteliales/química , Heces/citología , Alimentos , Humanos , Receptores de Hialuranos/análisis , Mucosa Intestinal/citología , Mucosa Intestinal/metabolismo , Tocoferoles/análisis , Vitamina A/análisis
8.
Rozhl Chir ; 84(6): 281-5, 2005 Jun.
Artículo en Checo | MEDLINE | ID: mdl-16149221

RESUMEN

BACKGROUND: Current screening methods of colorectal carcinoma are based on examination of occult bleeding in the stool, and further on endoscopic and irrigographical (barium enema) examinations. Population-based non-invasive screening method having high sensitivity and specificity is needed. METHODS: Detection of molecular alterations in colonocytes from the stool may be a promising new diagnostic tool for such screening. Determination of mutations in APC, K-ras, DCC, p53 genes and "long" DNA may serve for early detection of colorectal cancer from stool samples. Multi-target DNA-assays employing all these markers suggest high sensitivity and specificity, unfortunately also expensiveness. Therefore finding a marker characteristic for all tumor cells would be desirable. Nuclear faktor-kappaB (NF-kappaB) could be such marker suitable for determination in colonocytes shed into the stool. CONCLUSION: Molecular testing of stool for early detection of colorectal cancer may be a promising screening method for this disease. Large multicenter trials are required to validate results obtained from preliminary clinical studies.


Asunto(s)
Neoplasias Colorrectales/diagnóstico , Heces/citología , Genes Supresores de Tumor , Técnicas de Diagnóstico Molecular , Biomarcadores/análisis , Neoplasias Colorrectales/genética , ADN de Neoplasias/análisis , Humanos , Tamizaje Masivo
9.
J Antimicrob Chemother ; 36(1): 259-63, 1995 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-8537277

RESUMEN

We compared 40 patients taking lomefloxacin 400 mg once daily for 5 days in a double blind trial with 44 placebo takers with proven community acquired bacterial diarrhoea (85% due to Campylobacter spp.). Lomefloxacin eradicated Campylobacter spp. in 75% but did not alter clinical outcome. Twenty-eight per cent of the campylobacter isolates developed resistance. Thirty-three per cent developed side-effects. Lomefloxacin is not recommended for community-acquired bacterial diarrhoea when Campylobacter spp. predominate.


Asunto(s)
Antiinfecciosos/uso terapéutico , Infecciones Comunitarias Adquiridas/tratamiento farmacológico , Diarrea/tratamiento farmacológico , Fluoroquinolonas , Quinolonas/uso terapéutico , Adulto , Antiinfecciosos/efectos adversos , Antiinfecciosos/farmacología , Campylobacter/efectos de los fármacos , Infecciones por Campylobacter/tratamiento farmacológico , Infecciones por Campylobacter/microbiología , Infecciones Comunitarias Adquiridas/microbiología , Diarrea/microbiología , Método Doble Ciego , Farmacorresistencia Microbiana , Heces/citología , Heces/microbiología , Femenino , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Quinolonas/efectos adversos , Quinolonas/farmacología
10.
Rev Infect Dis ; 13 Suppl 4: S347-50, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-2047661

RESUMEN

The effect of antibiotic therapy on intake of food and absorption of nutrients for 19 male children aged 1-5 years with suspected shigella infection was studied. The children were admitted to the hospital with acute diarrhea, high fever, abdominal pain, and greater than or equal to 25 red blood cells and white blood cells per high-power field in the stool. Microbiologic diagnosis was made within 48 hours of admission. On the basis of clinical and microbiologic criteria, children were classified as having mild or severe infection. Ten children with mild infection did not receive antibiotics, whereas nine children with severe infection were treated with ampicillin. After the children were rehydrated, a 72-hour balance study was carried out during the acute stage of infection with Shigella and was repeated 2 weeks after recovery. The levels of consumption of food and absorption of nutrients were estimated. During the acute stage of infection, such levels were higher for the children treated with antibiotics than for the untreated group. During the recovery phase, the levels of intake of food and absorption of nutrients were equal for both groups. Thus, children who are treated with appropriate antibiotics not only may recover from infection with Shigella more rapidly, but they also may be able to absorb nutrients more efficiently.


Asunto(s)
Antibacterianos/uso terapéutico , Diarrea/metabolismo , Disentería Bacilar/metabolismo , Ingestión de Alimentos/efectos de los fármacos , Absorción Intestinal/efectos de los fármacos , Enfermedad Aguda , Antibacterianos/farmacología , Preescolar , Diarrea/tratamiento farmacológico , Carbohidratos de la Dieta/administración & dosificación , Carbohidratos de la Dieta/metabolismo , Grasas de la Dieta/administración & dosificación , Grasas de la Dieta/metabolismo , Disentería Bacilar/tratamiento farmacológico , Electrólitos/sangre , Ingestión de Energía , Recuento de Eritrocitos , Heces/citología , Humanos , Lactante , Recuento de Leucocitos , Masculino , Nitrógeno/administración & dosificación , Nitrógeno/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA